Download PDF
Horm Metab Res 2025; 57(01): e1
DOI: 10.1055/a-2575-5491
Retraction Note

Retraction Note: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes

Authors

  • Ziliang Shi

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China

  • Zi Sang

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China

  • Junmeng Xiao

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China

  • Jianbin Hou

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China

  • Mingfei Geng

    1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
Further Information
Also available at
   Permissions and Reprints

This Note retracts:

Retracted Article: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related GenesHorm Metab Res 2025; 57(01): 55-66
DOI: 10.1055/a-2458-7088

Retraction

The article titled “Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes,” published in Horm Metab Res, Volume 57, Number 01, 55–66, (DOI: 10.1055/a-2458-7088), has been retracted at the request of the authors due to an irreconcilable dispute which was only made known post-publication.



Publication History

Article published online:
07 April 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany